Identification | Back Directory | [Name]
N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea | [CAS]
133825-80-6 | [Synonyms]
ATR-101 PD-132301 ATR 101; ATR101; PD-132301 N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea Urea, N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]- | [Molecular Formula]
C27H39N3O | [MDL Number]
MFCD00899569 | [MOL File]
133825-80-6.mol | [Molecular Weight]
421.62 |
Chemical Properties | Back Directory | [Boiling point ]
528.1±50.0 °C(Predicted) | [density ]
1.062±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [pka]
13.91±0.46(Predicted) |
Hazard Information | Back Directory | [Uses]
Nevanimibe is an investigational drug being studied for the treatment of congenital adrenal hyperplasia (CAH). | [IC 50]
ACAT1: 9 nM (EC50); ACAT2: 368 nM (EC50) |
|
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Website: |
https://www.bocsci.com |
|